MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0036213
Novo Medi Sciences Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹96.23 Cr
▼ 3% YoY
Net profit · FY 2023
₹52.95 Lakh
Net margin 0.6%
EBITDA · FY 2023
₹10.19 Cr
EBITDA margin 10.6%
Authorised capital
₹19.7 Cr
Registered with MCA
Paid-up capital
₹19.7 Cr
Issued & subscribed
Open charges
₹30 Cr
Satisfied ₹52.63 Cr
Company age
13 yrs
Est. 2013
Employees · EPFO
262
Provident fund records
About Novo Medi Sciences Private Limited
Data last updated:
Novo Medi Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 June 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33110MH2013PTC245027. Its GSTIN is 27AAECN3915G1ZJ (Maharashtra).
The company has an authorised share capital of ₹19.7 Cr and a paid-up capital of ₹19.7 Cr. It is led by directors including Anju Sunil Kaudanya and Vipulkumar Rameshchandra Bhagat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2023, the company reported a revenue of ₹96.23 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹52.95 Lakh (net margin 0.6%) and EBITDA of ₹10.19 Cr (EBITDA margin 10.6%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 16% over five years.
The company has about 262 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Novo Medi. As per MCA filings, the company has open charges of ₹30 Cr and satisfied charges of ₹52.63 Cr on record. Court records list 20 cases involving the company, including 14 filed by the company and 6 filed against it; 6 cases are pending. The company has 5 deals on record (3 secondary share transfers, 2 rights issues); the latest was in October 2023. The company has 1 MSME Form 1 return on record for the period ending Mar 2021, listing 1 overdue payment to 1 micro and small supplier.
Novo Medi Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0036213). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website novomedi.com.
Company details
CIN U33110MH2013PTC245027
Registration Number 245027
Incorporation Date 29 June 2013
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0036213
Key People
Anju Sunil Kaudanya Director Vipulkumar Rameshchandra Bhagat Director Forum Vipulkumar Bhagat Director Recognitions & Rankings of Novo Medi Sciences
Contact details
Novo Medi Sciences Private Limited's registered office is in Mumbai, Maharashtra. Its website is novomedi.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1301 – 05 Comm. Awing Epicentre Wt Patil Marg, Borla Village Chembur (E), Mumbai, Maharashtra, India – 400071
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Novo Medi Sciences Private Limited, buy the company report.
Comprehensive company report
Novo Medi Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Novo Medi Sciences operates one associated brand: Novo Medi. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures vaccines for viral infections. | novomedi.com |
Business activity
The main business activity of Novo Medi Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Novo Medi Sciences Private Limited, buy the company report.
Financials of Novo Medi Sciences Private Limited
FY 2025 filings availableNovo Medi Sciences Private Limited reported revenue of ₹96.23 Cr (down 3% YoY) for FY 2023.
Revenue · FY 2023
₹96.23 Cr ▼ 3%
Net profit · FY 2023
₹52.95 Lakh margin 0.6%
EBITDA · FY 2023
₹10.19 Cr margin 10.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 7%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▼ 20%
5 years · compounded
▲ 31%
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 16%. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹96.23 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.19 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹52.95 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.6% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Novo Medi Sciences Private Limited, buy the company report.
Board of directors of Novo Medi Sciences Private Limited
Novo Medi Sciences has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anju Sunil Kaudanya | Director | 29 Jun 2013 | 13 Years 4 Months | Current |
| Vipulkumar Rameshchandra Bhagat Also directs: Novo Biologicals Private Limited, Novo Biosciences LLP | Director | 29 Jun 2013 | 13 Years 4 Months | Current |
| Forum Vipulkumar Bhagat Also directs: Novo Biologicals Private Limited | Director | 15 Sep 2015 | 11 Years 1 Months | Current |
| Karan Vipul Bhagat Also directs: Novo Biologicals Private Limited, Novo Biosciences LLP | Director | 30 Sep 2016 | 10 Years 1 Months | Current |
Auditor
Novo Medi Sciences Private Limited is audited by G.V. Samant & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G.V. Samant & Co. | FY 2023 | 0117789W |
Shareholding
The shareholding of Novo Medi Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Novo Medi Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹30 Cr
Satisfied charges
₹52.63 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Nov 2023 | 100835003 | Others | ₹30 Cr | Open | |
| 17 Sep 2021 | 100486202 | Others | ₹1.25 Cr | Satisfied | |
| 17 Sep 2021 | 100486203 | Others | ₹1.42 Cr | Satisfied | |
| 17 Sep 2021 | 100486204 | Others | ₹48 Lakh | Satisfied | |
| 17 Sep 2021 | 100486205 | Others | ₹8.4 Cr | Satisfied |
To see the full charge records of Novo Medi Sciences Private Limited, buy the company report.
Total charge records: 11 View all charges
Deals & funding
Novo Medi Sciences Private Limited has 5 deals on record (3 secondary share transfers, 2 rights issues); the latest was in October 2023.
Total deals
5
Secondary share transfers
3
Rights issues
2
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2023 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Mar 2018 | Rights issue | ₹16.7 Cr | Investors: 3 individuals |
| Oct 2015 | Rights issue | ₹2.99 Cr | Investors: 3 individuals |
| Oct 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Novo Medi Sciences Private Limited has 20 court cases on record: 14 filed by Novo Medi Sciences, 6 filed against it. 6 cases are pending and 14 are disposed.
Total cases
20
Filed by the company
14
Filed against the company
6
Pending
6
Disposed
14
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 12 | 6 | 5 |
| District courts | 8 | 0 | 1 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Sun Pharma Laboratories Ltd. | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Sun Pharma Laboratories Ltd. | Pending |
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Sun Pharma Laboratories Ltd. | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed by the company against Sun Pharma Laboratories Ltd and Anr | Pending |
| High Court | Interim or miscellaneous application | Filed against the company by Sun Pharmaceutical Industries Limited | Disposed |
To see the full case history of Novo Medi Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Novo Medi Sciences Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2021, listing 1 overdue payment to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Manisha Analytical Laboratories Private Limited |
To see the full MSME payment records of Novo Medi Sciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Novo Medi Sciences Private Limited has a workforce of 262 employees on its EPFO records as of Apr 19, 2024, across 1 active EPFO establishment.
Employee count
262
Active EPFO establishments
1
Employee growth
-0.76%
GST
Novo Medi Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECN3915G1ZJ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Novo Medi Sciences Private Limited, buy the company report.
Recent activity
Novo Medi Sciences Private Limited has 4 board changes on record since 2013: 4 appointments. The latest: Karan Vipul Bhagat was appointed as Director on 30 Sep 2016.
AGM
Novo Medi Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 30.00 Cr registered on 17 Nov 2023 with Charge ID 100835003 was modified on 08 Apr 2025.
Filing
Novo Medi Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 17 Sep 2021 via Charge ID 100486202 with Others was fully satisfied on 26 Dec 2023.
Charges
A charge registered on 17 Sep 2021 via Charge ID 100486203 with Others was fully satisfied on 26 Dec 2023.
Charges
A charge registered on 17 Sep 2021 via Charge ID 100486204 with Others was fully satisfied on 26 Dec 2023.
Charges
A charge registered on 17 Sep 2021 via Charge ID 100486205 with Others was fully satisfied on 26 Dec 2023.
Charges
A charge registered on 17 Sep 2021 via Charge ID 100486210 with Others was fully satisfied on 20 Dec 2023.
Charges
A charge with Others amounted to Rs. 30.00 Cr with Charge ID 100835003 was registered on 17 Nov 2023.
Charges
A charge with Others of Rs. 18.25 Cr registered on 17 Sep 2021 with Charge ID 100486210 was modified on 28 Nov 2022.
Charges
A charge registered on 20 Jul 2020 via Charge ID 100405632 with Others was fully satisfied on 28 Dec 2021.
Charges
A charge registered on 01 Jul 2020 via Charge ID 100405641 with Others was fully satisfied on 28 Dec 2021.
18 earlier events are in the company report.
Frequently asked questions
Novo Medi Sciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 June 2013 (13+ years old) and is registered under CIN U33110MH2013PTC245027.
Novo Medi Sciences has 4 current directors:
- Anju Sunil Kaudanya - Director
- Vipulkumar Rameshchandra Bhagat - Director
- Forum Vipulkumar Bhagat - Director
- Karan Vipul Bhagat - Director
The latest financial statements of Novo Medi Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Novo Medi Sciences is 27AAECN3915G1ZJ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Novo Medi Sciences is U33110MH2013PTC245027. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novo Medi Sciences has 20 court cases on record: 14 filed by the company and 6 filed against it. 6 are pending. Most are in the high courts.
Novo Medi Sciences was incorporated on 29 June 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
Novo Medi Sciences has 5 deals on record (3 secondary share transfers, 2 rights issues); the latest was in October 2023.
Karan Vipul Bhagat was appointed as Director on 30 Sep 2016. Forum Vipulkumar Bhagat was appointed as Director on 15 Sep 2015. Anju Sunil Kaudanya was appointed as Director on 29 Jun 2013. Novo Medi Sciences has 4 board changes on record in total.
Yes, Novo Medi Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0036213).
Novo Medi Sciences has 1 MSME Form 1 return on record for the period ending Mar 2021, listing 1 overdue payment to 1 micro and small supplier. The latest return was filed on 13 May 2021.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages